The adverse events induced by drugs have been complicated, when two or more drugs are administrated for a patient. We selected "Stevens-Johnson Syndrome (SJS)" as a research object, which is one of the severe skin manifestations. The data source is a database constructed by the Food and Drug Administration (FDA). FDA's post-marketing safety surveillance program is supported by the Adverse Event Reporting System (AERS). AERS is designed with a computerized information database. To analyze the relationships between the concurrent medication and SJS in this study, we applied association rule learning. Our purpose is to propose an efficient procedure that enables the detection of signals for drugs related to an adverse event, without assuming the involvement of a specific drug. We defined new value K for the evaluation of existing signal detection. Association rule was evaluated according to criterion K value. As a result, it was suggested to obtain a strong signal by combining two concomitant drugs. Association rule learning in this study was applicable for the analysis of the relationships between adverse events and pairs of drugs.
Introduction
The combined use of multiple drugs has become common in medical care and adverse events due to drug complications have resulted [1] . Consequently, the development of an effective technique for analyzing adverse experiences in cases where two or more drugs are used together is required. In recent years, the progress of information technology has made it easy to evaluate as well as to store large quantities of data in phamacovigilance. In addition, the Ministry of Health, Labour and Welfare in Japan and the Food and Drug Administration (FDA) in the United States have constructed their own original databases of adverse events attributable to drugs [2] . The extraction of the valuable information from these databases is therefore considered to be very important tasks. In Europe and the United States a method for finding significant relationships between adverse events and drugs from such databases, as well as a method for assigning priority for investigations, have already been implemented. This method is known as "signal detection", where "signal" is defined by the World Health Organization (WHO) as being "reported information on a possible causal relationship between an adverse event and a drug, the relationship being unknown or incompletely documented previously" [3] [4] [5] . In Japan, the research of applying the data mining methods to the database of the side effects has been started. [6] Although it is not about the side effect of the drug, for example, K. Hasegawa et al. applied rule mining methods, such as Rough Set theory, to the activity of dihydrofolate reductase inhibitors [7] . They concluded that rule mining is powerful for those purposes. On the other hand, in medical field Pharmaceuticals and Medical Devices Agency (PMDA) is establishing the method for signal detection which is one of data mining methods. And then we used rule mining to discover the side effect of the drugs. [6] Although Stevens-Johnson syndrome (SJS) is assumed to be caused by drugs, the detail on pathogenesis is still unclear. It has severe symptoms and a high fatality rate [8] . We therefore selected the relationships between the combined use of two drugs and SJS as a target, and developed a new procedure that applies both signal detection and a data mining method to a database. We selected the cases of patients who used more than one drug in the Adverse Event Reporting System (AERS), a database constructed by the FDA and designed as a post-marketing safety surveillance program [9] . To investigate the relationships between the combined use of drugs and SJS in this study, we applied association rule learning [10, 11] , which is a data mining technique used to identify relationships (i.e., rules) between objects in a database. We also propose an efficient procedure for detecting signals for drugs related to an adverse event, without assuming the involvement of a specific drug.
2．Method
The drugs stored in the AERS database are classified as follows: PS (Primary Specific Drug), SS (Secondary Specific Drug), C (Concomitant), and I (Interacting). In this study, we first applied our new procedure to the database without using classifications (PS, SS, C, I) and subsequently verified whether our results are similar to the classification of PS. Additionally, we evaluated whether the results, which were obtained using our new procedure, contain the drugs known to cause the adverse events compiled in the Japanese Ethical Drug Package Insert (EDPI). The dataset was extracted from AERS files using Microsoft Office Access 2003 and the statistical analyses of the data were performed using Microsoft Office Excel 2003. All graphs were plotted using Spotfire.
Our new procedure adopted both association rule learning and the signal detection method used by the Medicines and Healthcare Products Regulatory Agency (MHRA) [12] in the United Kingdom. A description of the dataset and both methods are described briefly in this section.
1 Dataset
This study used the AERS dataset in 2004. The file names and number of cases contained in each file are shown in Table 1 . First, we retrieved the patients from the REACTION file using the keyword "SJS" and then selected the suspected drugs from the DRUG file. However, the names of the drugs in the DRUG file are product names, generic names with or without salts, acids and bases, and others were mixed together. Therefore, we assigned a synonym for each generic name based on the dictionary provided by the FDA [13] and then created the "keyword file", which consists of the list of synonyms. For instance, "LOXONIN" is the synonym for "LOXONIN (LOXOPROFEN SODIUM)", "LOXONIN TABLETS", "LOXOPROFEN", and "LOXOPROFEN SODIUM". Subsequently, the names that are not listed in the dictionary were searched in PubMed and at the web sites of manufacturers. Any drugs with generic names that could still not be resolved were excluded from the analysis. Although the drug is administered by the various routes such as oral, trans dermal or eye drop, we leave the differences between administration routes of the drug out of consideration in order to look for all the possibilities in this study. Finally, we unified the drug names included in the dataset by using the list of synonyms in the "keyword file" and then collected information for those cases with "SJS" listed in both of the REACTION and DRUG files. The number of patients obtained from the search using "SJS" as a keyword was 748 and the number of drugs that were suspected to cause SJS was 672. We also noted the therapeutic categories in which many specific drugs are suspected of being the cause of SJS or toxic epidermal necrolysis (TEN), such as central nervous system agents, antipyretic, analgesic and antiphlogistic drugs, antibacterial drugs and hyperuricemia drugs. Table 2 shows the list of specific drugs that are suspected to be causative drugs for SJS and TEN, which is considered a severe form [14] of SJS by the Pharmaceuticals and Medical Devices Safety Information No. 218 [15] .
Association rule learning and correlation data analysis
If the association rule X  Y is true, then the support and confidence values can be calculated to evaluate the correlation of this rule. The support value is the rate at which X or Y appears in all transactions (T), and can be calculated by equation (2.1) .
That is, the support value shows the rate of the analyzed event in all transactions. The confidence value is the rate of events where both X and Y occur in all X, as described by equation (2.2),
Application of association rules
The following two association rules for relationships between the combined use of two drugs and SJS using our proposed procedure are constructed and evaluated.
Combined use of two drugs
We apply association rule learning with the rule described in equation (2.3) below.
(2.3) 
In general, an association rule with high support and confidence values is evaluated as a strong relationship. Therefore, in this study, we investigated whether the support and confidence values enable us to evaluate the [15] .
relationship between the combined use of drugs and SJS by examining their correlation coefficients.
Discrete use of two drugs
We apply association rule learning with the rule described in equation (2.7) Since both the hypothesis and conclusion are related to SJS in this rule, there is a possibility that the signal is detected from respective drugs D 1 and D 2 . The rule indicated in equation (2.7) is called the "discrete use of two drugs" in our new procedure. The support and confidence values of each drug are calculated for all pairs of drugs from the dataset consisting of patients who have SJS. The support and confidence values of the rule indicated in equation (2.7) can be represented as follows:
Signal detection method
In our procedure, to evaluate the relationship between the combined use of drugs and SJS obtained from association rule learning, we apply the signal detection method, which has previously been used to analyze the side effects of a drug by the MHRA [16] . MHRA uses the proportional reporting ratio (PRR) [17, 18] , chi-squared distribution (χ 2 ) and the number of cases reported about the adverse event as signal detection method.
For example, according to the MHRA, the combination of a specific drug and side effect is evaluated as a signal when each value is as follows [19] :
1.
The ratio of the proportion of reported cases of the event of interest among all cases in which a particular drug is used, compared to the corresponding proportion of all cases where other drugs are used, is higher than or equal to 2 (that is, PRR  2); 2.
 2 indicates the difference between the expected frequency and observed frequency, so it is evaluated as exhibiting a sufficiently significant difference when its value is higher than or equal to 4 (that is,  2  4); 3.
The number of reported cases in which the combination of the specific drug and side effect is higher than or equal to 3 (that is, the number of specific cases  3).
Kubota suggests that because PRR values show the generation ratio of adverse events, the result is evaluated regardless of sample size and the value of χ 2 is important when examining the total sample size [20] ; thus, drugs with high log PRR and log  2 values are evaluated as having a strong signal. Consequently, in our new procedure, the strength of the signal is indicated by K, as shown in equation (2.10).
Combination of association rule learning and signal detection method
In our study, the confidence value in association rule is added to the rule of signal detection method in the United Kingdom explained by the above-mentioned. To verify our method, we checked the relationship between results, using the following procedure. First, log PRR and log χ 2 are calculated for all drugs by using equations (2.11), (2.12) and Table3, and the correlation coefficient between log PRR and log χ 2 is calculated.
Second, drugs are selected based on the confidence value or support value using association rule learning, and on the number of reported cases in which the combination of the specific drug and the incidence of SJS is greater than or equal to either 2 or 3 according to the signal detection method of the MHRA. Log PRR and log χ 2 are calculated for the selected drugs, and the correlation coefficient between log PRR and log χ 2 is calculated. Finally, the *: a specific pair of drugs is used for "combined use of two drugs" and a specific drug is used for "discrete use of two drugs". difference between both above-mentioned correlation coefficients is evaluated to determine whether the selection based on the results of data mining and signal detection improves the correlation coefficient, and whether the selected drugs related to SJS are same as the drug in Table 2 . This evaluation is carried out for both rules:
"combined use of two drugs" and "discrete use of two drugs." Figure 1 shows schematic figures of the calculations in both rules. Two drugs are scanned in the patient group of SJS in association rule of this study.
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In this figure, the calculations of drugD1 are shown. Confidence value, PRR, and  2 in drugD2 as well as drugD1 are calculated. Figure 2 shows the relationship between the confidence values calculated with (2.6) and the support values calculated based on the number of cases using both drugs D1 and D2. In association rule, high confidence value and support value that is not too small is index for evaluation. However, the drug previously described is not seen in Figure 2 . We planned to use either of confidence value or support value. We use confidence value because variance of confidence value is larger than support value. number of cases, log PRR and log χ 2 are selected as indexes for detecting a signal in this procedure. In our new procedure, the higher the correlation coefficient between log PRR and log χ 2 , the stronger signal. Thus, when the conditions using the confidence value and the number of cases are set, their availability is evaluated based on the correlation coefficients between log PRR and log χ 2 . In Figure 3 , A and B show log PRR and log χ 2 calculated from the pairs of drugs selected based on the condition that the number of cases in which SJS occurred is greater than or equal to 2 and 3, respectively. The orthogonal straight line, which is the approximate line for the minimum sum of the squares of the distances between the line and the points, is plotted in each graph; the correlation coefficients are 0.921 and 0.945 for A and B in Figure 3 , respectively. The correlation coefficient between log PRR and log χ 2 calculated for all cases is 0.784 (shown by the solid and open squares in both figures). In To evaluate both log PRR and log  2 simultaneously, K was calculated for each drug using equation (2.10) and K values were sorted in descending order. The lower limit of the top 10% of K values was 4.65. The pairs of drugs selected by the application of the association rule with "combined use of two drugs" are categorized as class 1, 2, or 3 based on the conditions shown in Table 4 ; that is, the drugs classified as belonging to class 1 have strong signals. The list of drugs included in the pairs were evaluated as being signals and the categories suspected as having a relationship with SJS, such as antipyretic, analgesic and antiphlogistic drugs and central nervous system agents, are presented in Table 5 . Of the drugs listed in the Pharmaceuticals and Medical Devices Safety Information No. 218 [12] , acetaminophen, diclofenac, levofloxacin, phenytoin and loxoprofen were categorized according to signal strength as class 1; alloprinol was class 2; and phenobarbital and carbamazepine were class 3. Figure 4 shows the log PRR and log  2 calculated from the drugs selected based on the conditions for which confidence values were greater than or equal to 0.3 and the number of cases was greater than or equal to 3. K calculated using equation (2.10) is used as an index of signal strength.
Results
Combination of association rule learning and modified signal detection method
Discrete use of two drugs
The correlation coefficient was lower than that obtained for the "combined use of two drugs" (r 2 =0.516). The list of drugs evaluated as being signals and included 
Central nervous system agents
carbamazepine  topiramate  gabapentin  phenytoin  lamotrigine  divalproex  phenobarbital  zonisamide 
Drug for
hyperuricemia allopurinol  *: class 1, **: class 2, ***: class 3 based on Table4
The underlined drugs are included in Table 2. log chi-squared log PRR in the categories suspected as having a relationship with SJS is presented in Table 6 . In Table 6 , only loxoprofen was detected among the drugs shown in Table 2 .
Discussion
The pathogenesis of SJS has not been entirely clarified. However, the generally accepted explanation is that drug administration is the most related factor [21] . A large number of SJS cases are reported in the AERS database, and the use of data mining methods to discover the potential associations between the drugs used and incidence of SJS has been demonstrated to be effective.
Since the AERS dataset in 2004 has sufficient information for the application of data mining methods, we used association rule learning. To elucidate the relationships between the combined use of two drugs and SJS in this study, patients administered more than two drugs in combination were selected for analysis. Our new procedure enabled us to evaluate the two drugs simultaneously, without identifying the specific drugs being used. In our new procedure, the number of cases is adopted as one of the indexes used for assessing the significance of the proposed association because it is one of the conditions used for signal detection by the MHRA [12] . In addition, the lower limit was also set to 3, which is the same as that employed by MHRA. To determine the limit of the confidence value used for selecting the drug pairs related to the onset of SJS, the number of selected pairs was counted when certain limit values were applied. When confidence value limits were set to 0.1, 0.2, 0.3 and 0.4, the obtained ratios of the selected pairs to all pairs were 58%, 40%, 24% and 13%, respectively. We considered that approximately one-fourth [22] of all results are suitable for selection; therefore, the lower limit of the confidence value was taken as 0.3. Out of nine drugs and one drug combination described as being the "most numerously reported suspected drugs" in Pharmaceuticals and Medical Devices Safety Information No. 218 [12] ( Table 2) , only one drug was detected by the association rule when the "discrete use of two drugs" was applied; however, eight drugs, not including combination drugs, were detected when the "combined use of two drugs" was applied, five of which belong to class 1.
The K value enables us to compare the strength of the signal obtained from each drug. However, the correlation between log PRR and log χ 2 in the results of the association rule applied together with "discrete use of two drugs" was weaker than that of "combined use of two drugs", and the evaluation of the strength of the signal in each drug based on the confidence value was inappropriate. Accordingly, signal detection using the association rule combined with the "combined use of two drugs" is more sensitive than when applied in conjunction with the "discrete use of two drugs."
Additionally, among the categories suspected as having a relationship with SJS, the following drugs were detected: antipyretic, analgesic and antiphlogistic drugs and central nervous system agents. In the antipyretic, analgesic and antiphlogistic drug category, acetaminophen which was considered to be comparatively safe for people of all ages, and valdecoxib which was discontinued due to the occurrence of serious adverse events in May 2005, were detected as signals [23] . In the antibacterial agent category, azithromycin, which was linked with SJS in Japan in 2003, was detected as a signal. In other categories, lamotrigine [24, 25] , which was put on the market in 2008 in Japan, and gabapentin, which obtained manufacturing approval as an antiepileptic agent in July 2006 in Japan, were also detected, although the signal for gabapentin was weak. Our new procedure including the association rule with "combined use of two drugs" enables us to detect such an important signal early.
Conclusion
We developed a new procedure that applies both a signal detection method and a data mining technique to the adverse event database AERS compiled by the FDA [26] . Results suggest that our new procedure is appropriate for predicting causal drugs at an early stage. Moreover, PS is predictable using our proposed method.
The association rule learning in this study was Table 2 .
applicable to the analysis of relationships between adverse events and pairs of drugs. However, in addition to drugs, adverse events can be attributed to several other factors. It is therefore hoped that the analytical tools required for identifying risk factors other than drugs will be developed. These developments and applications would enable us to obtain more information about such risk factors and, most importantly, enable medical staff to make more accurate diagnoses.
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